arteflene

09/01/1994 - "Ro 42-1611 in the treatment of patients with mild malaria: a clinical trial in Nigeria and Burkina Faso."
09/01/1994 - "An open, non-comparative clinical trial was carried out in Nigeria and Burkina Faso to investigate the safety and efficacy of the novel antimalarial arteflene in patients with mild malaria. "
09/01/1994 - "Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in Cameroon."
09/01/1994 - "The novel antimalarial Ro 42-1611 (arteflene) was evaluated for safety and efficacy in an open, non-comparative study of patients with mild malaria in the south of Cameroon. "
09/01/1994 - "Ro 42-1611 (arteflene) is a new synthetic structural analogue of yingzhaosu, a Chinese traditional herbal drug, now under development for treatment of malaria. "

09/01/1996 - "Arteflene cleared fever slightly but not significantly faster than mefloquine and the 50% and 90% parasite clearance times were comparable in both treatment groups. "

06/01/1995 - "Ro 42-1611 only slightly suppressed cytoadherence of infected erythrocytes to melanoma cells. "
06/01/1995 - "The purpose of this study was to investigate the ability of the antimalarial drug, Ro 42-1611 to block parasite mediated cytokine induction in vitro as well as cytoadherence of infected erythrocytes to melanoma cells in vitro. "

09/01/1996 - "Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children."
06/01/1995 - "The antimalarial drug, Ro 42-1611 (arteflene), does not affect cytoadherence and cytokine-inducing properties of Plasmodium falciparum malaria parasites."